Why the Indobufen Tablets Market Is Gaining Pain Management Attention
The global Indobufen Tablets market is expanding against a backdrop of rising prevalence of rheumatic diseases, aging populations, and growing demand for non-opioid pain management options. The market was valued at USD 3.29 billion in 2024 and is projected to reach USD 4.8 billion by 2032, registering a CAGR of 4.83% over the forecast period. What makes this market particularly notable is the...
0 Commenti 0 condivisioni 3 Views 0 Anteprima